This peptide may alleviate pain, improve blood flow, and correct digestive disorders
This article is for informational purposes only and does not provide medical advice, diagnosis, or treatment
Dr Micklewright said: I am seeing more private businesses operating that offer these research-only peptides to patients and justify their practice by asking patients to sign disclaimers, accepting the risks and consenting to the treatment. Private clinic owner Dr Omar acknowledged this, saying: The key thing for users to understand is that these products are unlicensed and we make clear during the consenting process as to the implications of this informed consent is vital. In terms of delivering unlicensed peptide therapies safely, he added: We have a decent amount of information on how certain peptides work, some peptides are already licensed, and we have detailed information on dosing and side effects. At [our clinic], we have experience using peptides for various use scenarios and have access to a network of doctors across UK and the US where we can share data and knowledge on how to best use peptides, their side effects, and how to best dose them. Suppliers, meanwhile, maintain that they operate within current guidance
IAP-antagonists exhibit non-redundant modes of action through differential DIAP1 binding
